William Blair Comments on Incyte’s Q4 Earnings (NASDAQ:INCY)
Incyte Co. (NASDAQ:INCY – Free Report) – Research analysts at William Blair increased their Q4 2025 EPS estimates for Incyte in a report issued on Tuesday, April 29th. William Blair analyst M. Phipps now anticipates that the biopharmaceutical company will earn $1.25 per share for the quarter, up from their prior estimate of $1.16. William […]
Incyte Co. (NASDAQ:INCY – Free Report) – Research analysts at William Blair increased their Q4 2025 EPS estimates for Incyte in a report issued on Tuesday, April 29th. William Blair analyst M. Phipps now anticipates that the biopharmaceutical company will earn $1.25 per share for the quarter, up from their prior estimate of $1.16. William […]
